Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct:48:581-591.
doi: 10.1016/j.ebiom.2019.09.032. Epub 2019 Oct 15.

Natural history of SPINK1 germline mutation related-pancreatitis

Affiliations

Natural history of SPINK1 germline mutation related-pancreatitis

Nelly Muller et al. EBioMedicine. 2019 Oct.

Abstract

Background: The aim was to describe genetic, clinical and morphological features in a large, multicentre European cohort of patients with SPINK1 related pancreatitis, in comparison with patients with idiopathic pancreatitis (IP).

Methods: All SPINK1 mutation carriers with pancreatic symptoms from two French and one English centers were included. Patients with IP were included in a control group. Genetic, clinical, radiological and biochemical data were collected.

Findings: 209 and 302 patients were included in the SPINK1 and control groups (median follow-up: 8.3 years (3.7-17.4) vs 5.3 (2.5-8.8)). The median age at onset of symptoms was 20.1 years (17.5-22.8) in the SPINK1 group versus 41.2 (35.2-45.2). The age of exocrine pancreatic insufficiency (EPI) onset in the SPINK1 group was 49.5 (44.5-54.6) years vs. 65.2 (62.1-68.3), p < 0.001. SPINK1 patients with EPI were 5.3%, 14.7%, 28.3% and 52.4% at 20, 30, 40 and 50 years. Diabetes occurred 37.7 (33.3-42.1) years following the onset of symptoms in the SPINK1 group vs. 30.6 (17.3-43.8) (p = 0.002). SPINK1 patients with diabetes were 7.8%, 13.4%, 26.3% and 43.4% at 30, 40, 50 and 60 years. Seven patients (3.3%) developed pancreatic cancer in the SPINK1 group (versus 3 (0.99%), p = 0.1), at a median age of 60 vs 66 years. The cancer risk was 0.8% before 50 years, 11.9%, 27.7%, 51.8% at 60, 70 and 80 years and was 12 times higher than in controls (Cox HR 12.0 (3.0-47.8), p < 0.001).

Interpretation: SPINK1 related pancreatitis is associated with earlier onset and pancreatic insufficiencies. p.N34S SPINK1 may well be associated with cancer.

Keywords: Diabetes; Genetic; Pancreatic cancer; Pancreatic exocrine insufficiency; Pancreatitis; SPINK1.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest exist.

Figures

Fig. 1
Fig. 1
Cumulative incidence of symptoms depending on age.
Fig. 2
Fig. 2
Cumulative incidence of chronic pancreatitis depending on age (2a) and according to tobacco status (2b).
Fig. 3
Fig. 3
Cumulative incidence of steatorrhea depending on age (3a) and depending on tobacco status (3b).
Fig. 4
Fig. 4
Cumulative incidence of mellitus diabetes depending on age (4a) and depending on tobacco status (4b).
Fig. 5
Fig. 5
Cumulative incidence of pancreatic ductal adenocarcinoma cancer depending on age.

References

    1. Rebours V. The natural history of hereditary pancreatitis: a national series. Gut. 2009;58:97–103. - PubMed
    1. Laskowski M., Kato I. Protein inhibitors of proteinases. Annu Rev Biochem. 1980;49:593–626. - PubMed
    1. Witt H. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet. 2000;25:213–216. - PubMed
    1. Pfützer R.H. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology. 2000;119:615–623. - PubMed
    1. Threadgold J. The p.N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut. 2002;50:675–681. - PMC - PubMed

Substances